Mostra el registre parcial de l'element

dc.contributorUniversitat Ramon Llull. IQS
dc.contributor.authorDomínguez García, Pol
dc.contributor.authorOrtiz Almirall, Xavier
dc.contributor.authorGómez Canela, Cristian
dc.date.accessioned2025-04-08T14:11:51Z
dc.date.issued2025-02-15
dc.identifier.issn1873-6424ca
dc.identifier.urihttp://hdl.handle.net/20.500.14342/5223
dc.description.abstractThe impact of pharmaceuticals in aquatic environments requires complementary monitoring techniques to the more conventional grab sampling approach for an improved sample representativity. This study explores the application of Polar Organic Chemical Integrative Samplers (POCIS) in the analysis of a wide range of pharmaceutical residues in wastewater effluent, highlighting its advantages over grab sampling. Passive sampling techniques, extending sampling duration several days or weeks, provide continuous and representative data, improving the punctual nature of grab sampling. Despite their advantages, achieving quantitative results remains a challenge. Calibration through precise determination of sampling rates (RS) is recommended to convert the accumulated contaminant mass on the adsorbent to water concentrations. In the present work, 78 pharmaceuticals were preselected for stability suitability for POCIS passive sampling. RS were experimentally determined for 49 stable compounds: 33 of them had not been previously reported and most the other 16 agree with previous published literature. These RS were used to determine the concentration of pharmaceuticals in a wastewater treatment plant (WWTP) near to Barcelona, Spain over 3 weeks. High concentrations of 1,7-dimethylxanthine (2897 ng L-1), 4-acetamidoantipyrine (191 ng L-1), acetaminophen (165 ng L-1) and rasagiline (152 ng L-1) were found. This study examines POCIS deployment strategies, calibration, and analysis methods for 49 pharmaceutical compounds in an WWTP effluent. This research establishes a robust methodology for quantitative passive sampling of pharmaceuticals in aquatic environments, providing critical insights for more accurate monitoring of pharmaceuticals of environmental concern.ca
dc.format.extentp.45ca
dc.language.isoengca
dc.publisherElsevierca
dc.relation.ispartofEnvironmental Pollution 2025, 367ca
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalca
dc.rights© Elsevierca
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.otherEnvironmental monitoringca
dc.subject.otherPOCISca
dc.subject.otherPassive samplerca
dc.subject.otherPharmaceutical residuesca
dc.subject.otherSampling ratesca
dc.subject.otherWWTPca
dc.subject.otherSeguiment ambientalca
dc.subject.otherIndústria farmacèutica--Residusca
dc.subject.otherMostreigca
dc.titleA POCIS-based approach for the monitoring of pharmaceuticals in wastewater treatment plants: Calibration and deployment challengesca
dc.typeinfo:eu-repo/semantics/articleca
dc.rights.accessLevelinfo:eu-repo/semantics/embargoedAccess
dc.date.embargoEnd2027-02-15T01:00:00Z
dc.embargo.terms24 mesosca
dc.subject.udc502ca
dc.subject.udc615ca
dc.identifier.doihttps://doi.org/10.1016/j.envpol.2025.125641ca
dc.relation.projectIDinfo:eu-repo/grantAgreement/MCI/PN I+D/PID2020-113371RA-C22ca
dc.relation.projectIDinfo:eu-repo/grantAgreement/MCI/PN I+D/PID2020-113371RB-C21ca
dc.relation.projectIDinfo:eu-repo/grantAgreement/MCI i AEI/PN I+D/TED2021-130845A-C32ca
dc.description.versioninfo:eu-repo/semantics/acceptedVersionca


Fitxers en aquest element

Aquest document conté fitxers embargats fins el dia 15-02-2027

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Attribution-NonCommercial-NoDerivatives 4.0 International
Excepte que s'indiqui una altra cosa, la llicència de l'ítem es descriu com http://creativecommons.org/licenses/by-nc-nd/4.0/
Comparteix a TwitterComparteix a LinkedinComparteix a FacebookComparteix a TelegramComparteix a WhatsappImprimeix